Star Lake Bioscience Co (SHSE:600866) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600866 Star Lake Bioscience Co Inc SHSE:600866
70 GF Score
Price ¥5.01
GF Value ¥5.86
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Star Lake Bioscience Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:600866 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Star Lake Bioscience Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Star Lake Bioscience Co Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Short Interest falls into.


SHSE:600866
70GF Score
Star Lake Bioscience Co Inc SHSE:600866
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?

Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued. The current stock price of ¥5.01 is trading 14.5% below its estimated GF Value™ of ¥5.86. GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.

Key valuation signals for SHSE:600866:

  • Short Interest:
  • GF Value™: ¥5.86 vs. price of ¥5.01 (14.5% below fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Star Lake Bioscience Co Business Description

Address No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
70GF Score

Get the complete analysis for SHSE:600866

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.01
Price
¥5.86
GF Value